High-Flow Vascular Malformations in Children

Ramin A Morshed1, Ethan A Winkler1, Helen Kim2

  • 1Department of Neurological Surgery, University of California San Francisco, San Francisco, California.

Seminars in Neurology
|April 7, 2020
PubMed

Insights

This review covers high-flow pediatric intracranial vascular malformations, including brain arteriovenous malformations, dural arteriovenous fistulas, and vein of Galen malformations, detailing their causes, risks, and natural history.

Area of Science:

  • Pediatric Neurology
  • Vascular Malformations
  • Neurointerventional Radiology

Background:

  • Intracranial vascular anomalies in children present a spectrum from incidental findings to severe conditions impacting neurologic function, development, and cardiac health.
  • High-flow lesions, characterized by direct arterial-to-venous shunts, pose greater risks compared to low-flow lesions like cavernous malformations.
  • Effective management necessitates understanding treatment impacts on developing central nervous systems.

Purpose of the Study:

  • To review the etiologies, epidemiology, natural history, and genetic risk factors of three common high-flow intracranial vascular malformations in children.
  • To provide a comprehensive overview for clinicians managing these complex pediatric conditions.

Main Methods:

  • Literature review focusing on pediatric brain arteriovenous malformations, intracranial dural arteriovenous fistulas, and vein of Galen malformations.
  • Synthesis of data on disease mechanisms, prevalence, clinical course, and genetic predispositions.

Main Results:

  • Detailed discussion of the distinct characteristics of brain arteriovenous malformations, intracranial dural arteriovenous fistulas, and vein of Galen malformations.
  • Emphasis on the high-flow nature and associated clinical sequelae of these lesions.

Conclusions:

  • Understanding the specific features of these high-flow vascular malformations is crucial for appropriate diagnosis and management in pediatric patients.
  • Further research into genetic factors and long-term outcomes will aid in optimizing treatment strategies for children.